Literature DB >> 27694894

NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma.

C A Murga-Zamalloa1, V Mendoza-Reinoso1, A A Sahasrabuddhe1, D Rolland1,2, S R Hwang1, S R P McDonnell1, A P Sciallis1, R A Wilcox3, V Bashur1, K Elenitoba-Johnson1,2, M S Lim1,2.   

Abstract

Mechanisms by which NPM-ALK signaling regulates cell migration, invasion and contributes to the oncogenesis of anaplastic large cell lymphoma (ALCL) are not completely understood. In an attempt to identify novel actin signaling pathways regulated by NPM-ALK, a comprehensive phosphoproteome analysis of ALCL cell lines was performed in the presence or absence of NPM-ALK activity. Numerous phosphoproteins involved in actin dynamics including Wiskott-Aldrich syndrome protein (WASp) were regulated by NPM-ALK. Network analysis revealed that WASp is a central component of the NPM-ALK-dependent actin signaling pathway. Here we show that NPM-ALK phosphorylates WASp at its known activation site (Y290) as well as at a novel residue (Y102). Phosphorylation of WASp at Y102 negatively regulates its interaction with Wiskott-Aldrich interacting protein and decreases its protein stability. Phosphorylation of WASp at Y102 enhances anchorage-independent growth and tumor growth in an in vivo xenograft model and enhances invasive properties of ALCL. We show that knock-down of WASp or expression of Y102F mutant of WASp decreases colony formation and in vivo tumor growth. Our results show that WASp is a novel substrate of ALK and has a critical role in regulating invasiveness and oncogenesis of ALCL.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27694894     DOI: 10.1038/onc.2016.366

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

1.  Pyrazolone-based anaplastic lymphoma kinase (ALK) inhibitors: control of selectivity by a benzyloxy group.

Authors:  Rabindranath Tripathy; Robert J McHugh; Arup K Ghose; Gregory R Ott; Thelma S Angeles; Mark S Albom; Zeck Huang; Lisa D Aimone; Mangeng Cheng; Bruce D Dorsey
Journal:  Bioorg Med Chem Lett       Date:  2011-10-20       Impact factor: 2.823

2.  Blood leukocytes and macrophages of various phenotypes have distinct abilities to form podosomes and to migrate in 3D environments.

Authors:  Céline Cougoule; Emeline Van Goethem; Véronique Le Cabec; Fanny Lafouresse; Loïc Dupré; Vikram Mehraj; Jean-Louis Mège; Claire Lastrucci; Isabelle Maridonneau-Parini
Journal:  Eur J Cell Biol       Date:  2012-09-19       Impact factor: 4.492

3.  N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors.

Authors:  Bojana Gligorijevic; Jeffrey Wyckoff; Hideki Yamaguchi; Yarong Wang; Evanthia T Roussos; John Condeelis
Journal:  J Cell Sci       Date:  2012-02-01       Impact factor: 5.285

4.  Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity.

Authors:  Arianna Donella-Deana; Oriano Marin; Luca Cesaro; Rosalind H Gunby; Anna Ferrarese; Addolorata M L Coluccia; Carmen J Tartari; Luca Mologni; Leonardo Scapozza; Carlo Gambacorti-Passerini; Lorenzo A Pinna
Journal:  Biochemistry       Date:  2005-06-14       Impact factor: 3.162

5.  WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells.

Authors:  N Ramesh; I M Antón; J H Hartwig; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis.

Authors:  D Bischof; K Pulford; D Y Mason; S W Morris
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

7.  Matrix metalloproteinase-9 is upregulated in nucleophosmin-anaplastic lymphoma kinase-positive anaplastic lymphomas and activated at the cell surface by the chaperone heat shock protein 90 to promote cell invasion.

Authors:  Frédéric Lagarrigue; Sophie Dupuis-Coronas; Damien Ramel; Georges Delsol; Hélène Tronchère; Bernard Payrastre; Frédérique Gaits-Iacovoni
Journal:  Cancer Res       Date:  2010-08-10       Impact factor: 12.701

Review 8.  Structure and role of WASP and WAVE in Rho GTPase signalling in cancer.

Authors:  Jane Lane; Tracey Martin; Hoi Ping Weeks; Wen Guo Jiang
Journal:  Cancer Genomics Proteomics       Date:  2014 May-Jun       Impact factor: 4.069

9.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

10.  Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation.

Authors:  Loïc Dupré; Alessandro Aiuti; Sara Trifari; Silvana Martino; Paola Saracco; Claudio Bordignon; Maria-Grazia Roncarolo
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

View more
  8 in total

1.  Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.

Authors:  Carlos Murga-Zamalloa; Delphine C M Rolland; Avery Polk; Ashley Wolfe; Hiran Dewar; Pinki Chowdhury; Ozlem Onder; Rajan Dewar; Noah A Brown; Nathanael G Bailey; Kedar Inamdar; Megan S Lim; Kojo S J Elenitoba-Johnson; Ryan A Wilcox
Journal:  Clin Cancer Res       Date:  2019-10-21       Impact factor: 12.531

2.  Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma.

Authors:  Steven R Hwang; Carlos Murga-Zamalloa; Noah Brown; Johnvesly Basappa; Scott Rp McDonnell; Veronica Mendoza-Reinoso; Venkatesha Basrur; Ryan Wilcox; Kojo Elenitoba-Johnson; Megan S Lim
Journal:  Lab Invest       Date:  2017-04-17       Impact factor: 5.662

3.  The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model.

Authors:  Jiaxiong Lu; Shan Guan; Yanling Zhao; Yang Yu; Sarah E Woodfield; Huiyuan Zhang; Kristine L Yang; Shayahati Bieerkehazhi; Lin Qi; Xiaonan Li; Jerry Gu; Xin Xu; Jingling Jin; Jodi A Muscal; Tianshu Yang; Guo-Tong Xu; Jianhua Yang
Journal:  Cancer Lett       Date:  2017-04-26       Impact factor: 8.679

4.  WASP family proteins: Molecular mechanisms and implications in human disease.

Authors:  Daniel A Kramer; Hannah K Piper; Baoyu Chen
Journal:  Eur J Cell Biol       Date:  2022-06-01       Impact factor: 6.020

5.  Deficiency of Wiskott-Aldrich syndrome protein has opposing effect on the pro-oncogenic pathway activation in nonmalignant versus malignant lymphocytes.

Authors:  Seong-Su Han; Kuo-Kuang Wen; Yatin M Vyas
Journal:  Oncogene       Date:  2020-11-02       Impact factor: 9.867

Review 6.  From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL).

Authors:  Michael T Werner; Qian Zhang; Mariusz A Wasik
Journal:  Cancers (Basel)       Date:  2017-10-16       Impact factor: 6.639

Review 7.  Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining Lymphomagenesis.

Authors:  Valentina Fragliasso; Annalisa Tameni; Giorgio Inghirami; Valentina Mularoni; Alessia Ciarrocchi
Journal:  Front Oncol       Date:  2021-04-13       Impact factor: 6.244

Review 8.  Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma.

Authors:  Yuan Wang; Jing He; Manyu Xu; Qingfeng Xue; Cindy Zhu; Juan Liu; Yaping Zhang; Wenyu Shi
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.